Literature DB >> 8549417

Consequences of incomplete antibacterial treatment for chlamydial pelvic inflammatory disease.

M J Rosenberg1, M S Waugh.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 8549417     DOI: 10.2165/00003495-199500492-00151

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  5 in total

1.  Localization of Chlamydia trachomatis infection by direct immunofluorescence and culture in pelvic inflammatory disease.

Authors:  N B Kiviat; P Wølner-Hanssen; M Peterson; J Wasserheit; W E Stamm; D A Eschenbach; J Paavonen; J Lingenfelter; T Bell; V Zabriskie
Journal:  Am J Obstet Gynecol       Date:  1986-04       Impact factor: 8.661

2.  Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000.

Authors:  A E Washington; P Katz
Journal:  JAMA       Date:  1991-11-13       Impact factor: 56.272

3.  Infection with Chlamydia trachomatis, Mycoplasma hominis and Neisseria gonorrhoeae in patients with acute pelvic inflammatory disease.

Authors:  B R Møller; P A Mårdh; S Ahrons; E Nüssler
Journal:  Sex Transm Dis       Date:  1981 Jul-Sep       Impact factor: 2.830

4.  Compliance with antibiotic therapy for Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  B P Katz; B W Zwickl; V A Caine; R B Jones
Journal:  Sex Transm Dis       Date:  1992 Nov-Dec       Impact factor: 2.830

5.  Acute pelvic inflammatory disease in outpatients: association with Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  W R Bowie; H Jones
Journal:  Ann Intern Med       Date:  1981-12       Impact factor: 25.391

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.